Taris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 … GENERAL ELECTRIC IC9033B5C68 IC9033B5C68 (USED TESTED CLEANED)
| Condition: | Used | Model: | Momentum |
| Make: | Schneider/Gould/Modicon | Type: | Communication Module |
| Brand: | Modicon |
Listen to the recording of Reed Tech’s ‘Blanket No Change Certification webinar’ to learn about annual No Change Certification submission requirements for drug product listings and what steps are … [Read More...]
Becton Dickinson (NYSE:BDX) recalled nearly 3,000 leaky SmartSite syringe administration sets used in the neonatal intensive care unit in what the FDA deemed a Class I action.CROUZET 84137121 84137121 (USED TESTED CLEANED) Franklin Lakes, N.J.-based BD issued an urgent medical device recall in … [Read More...]
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company's initial focus on diabetes involves a smart, … RR DONNELLEY (4) 4 X 10 THERMAL TRANSFER LABELS 1B97263 NIB
The U.S. Securities & Exchange Commission this week accused a coterie of lawyers of securities fraud in connection with nearly $1.7 million in illicit stock sales involving PixarBio. The scheme began in the fall of 2014, the SEC alleged, when … Genuine Marcinkiewicz 5LD 24K gold Flugelhorn Mouthpiece NEW
Glaukos (NYSE:GKOS) said yesterday that closed the nearly $3 million plus milestones to acquire former subsidiary Dose Medical and its drug-delivery technology for treating retinal diseases. Sam Clemente, Calif.-based Glaukos spun Dose out as a … [Read More...]
Fresh off its $89.7 million jury award in a patent infringement case against GlaxoSmithKline (NYSE:GSK), British inhaler company Vectura has petitioned the court for an additional $44 million. NUMATICS ACTUATOR P2AK-01A1D-CAA0 NEW NO BOXOn May 16, a jury in U.S. District Court for the … [Read More...]
Apple (NSDQ:AAPL) is reportedly selling One Drop blood glucose monitors in a small number of its namesake stores in the U.S. One Drop is a compact blood glucose monitor that is compatible with the iOS Health app and the Apple Watch. The device is … Ampad® Perforated Writing Pad, 8 1 2 x 11 3 4, White, 50 Sheets, 074319203223
Taris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 … [Read More...]
Medtronic (NYSE:MDT) today recalled two models of its MiniMed insulin pumps after researchers discovered cybersecurity risks that could allow a hacker to take control of the devices. GHENT IMM44ESPF90 Fabric Bulletin Board 47-3 4x47-3 4 The recall affects 11 models in Fridley, Minn.-based Medtronic's … [Read More...]
Pharmaceutical giant AbbVie (NYSE:ABBV) said today it will acquire Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie's blockbuster drug, Humira. AbbVie … [Read More...]
An FDA advisory panel on paclitaxel-eluting devices for treating peripheral artery disease yesterday found that the mortality signal indicated by a meta-analysis last year exists but that further study is needed to determine whether it's a class … 10PCS Box NEW MITSUBISHI VBMT160408-MV VP15TF VBMT332MV
Square D 9998DP39 NSFP GENUINE 9998 DP 39Taris Biomedical today announced positive results from the second arm of a study of its TAR-200 system for the treatment of patients with muscle-invasive bladder cancer (MIBC). The most recent study arm involved 10 patients treated with TAR-200 and yielded positive safety, tolerability and preliminary efficacy data, according to Lexington, Mass.-based Taris. Combined data from […]
The American Diabetes Association’s 79th Scientific Sessions is a five-day conference where researchers and healthcare professionals share the latest in diabetes research. More than 180 sessions and over 2,000 research presentations took place during the meeting on June 7-11 in San Francisco. During the meeting, diabetes experts shared data and research from clinical trials. Here […]
Beta Bionics’ iLet bionic pancreas system significantly increased the percentage of time that adults with Type 1 diabetes spent with glucose levels between 70–180 mg/dl when compared to usual care therapy, according to a new study. The study’s results also suggest that the iLet, using either the Senseonics (NYSE:SENS) Eversense continuous glucose monitoring system (CGM) […]
Abbott (NYSE:ABT) said today that new data show its FreeStyle Libre continuous glucose monitoring (CGM) system significantly reduces hemoglobin A1c (HbA1c) levels in certain adults with type 2 diabetes. Presented as a late-breaker at American Diabetes Association (ADA) annual conference in San Francisco, the data represent what Abbott termed the first evaluation of real-world evidence from […]
Senseonics (NYSE:SENS) said yesterday that is presenting long-term safety data on its Eversense CGM from a European post-market clinical follow up registry later this week, touting that results showed the device as having a strong safety profile. The presentation is slated to take place this Saturday as part of the American Diabetes Association’s Scientific Sessions in […]
